!
TRIUMF's latest Coronavirus (COVID-19) advisories and updates are available here [Revised: September 17, 2021]
Home
Headlines & Research Highlights
TRIUMF and Fusion Pharmaceuticals announce expanded R&D collaboration for Actinium Supply Production
12 August 2021
The clinical-stage oncology company and TRIUMF announced their entry into the next phase of their collaboration agreement for the production of actinium-225.
Dr. Jens Dilling to become Director of Institutional Strategic Planning at ORNL
02 July 2021
After 20 years of service to TRIUMF, Jens Dilling will be departing the laboratory on July 31, 2021 to take on a new challenge as the Director of Institutional Strategic Planning at Oak Ridge National Laboratory in Tennessee.
TRIUMF joins RADNEXT infrastructure network
21 June 2021
TRIUMF has joined RADNEXT (‘RADiation facility Network for the EXploration of effects for indusTry and research’), a Horizons 2020 infrastructure project that will establish a global network of facilities and related irradiation methodology for responding to the emerging needs of electronics component and system irradiation.
Dr. Tom Ruth Awarded SNMMI’s 2021 George Charles de Hevesy Nuclear Pioneer Award
14 June 2021
TRIUMF Emeritus Senior Scientist Dr. Tom Ruth has been awarded the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 George Charles de Hevesy Nuclear Pioneer Award.
A message from the TRIUMF Board of Management: Finalization of Incorporation
01 June 2021
Effective today, TRIUMF has successfully completed its transition from a joint venture to a non-profit incorporation with charitable status.
TRIUMF welcomes next Director, Dr. Nigel Smith
17 May 2021
The TRIUMF community would like to share a warm welcome for the lab’s next Director, Dr. Nigel Smith, whose 5-year term as TRIUMF Director begins today.
University Partners & Owners
